Table 5.
Model 1: uCTXII only |
Model 2: uCTXII, sHA |
Model 3: uCTXII, sHA, uCTXI ALPHA |
Model 4: uCTXII, sHA, uCTXI ALPHA, uNTXI |
Model 5: uCTXII, sHA, uCTXI ALPHA, sNTXI |
Model 6: uCTXII, sHA, sNTXI |
|
---|---|---|---|---|---|---|
AUC (biomarkers only, no cross-validation) | 0.583 | 0.614 | 0.626 | 0.625 | 0.635 | 0.631 |
AUC (including covariates*, no cross-validation) | 0.646 | 0.660 | 0.668 | 0.669 | 0.672 | 0.667 |
AUC (including covariates*, 10-fold cross-validation) | 0.602 | 0.613 | 0.617 | 0.610 | 0.617 | 0.618 |
uCTXII | p=0.0006 | p=0.0057 | p=0.0625 | p=0.0662 | p=0.0636 | p=0.0129 |
z≤−1 vs −1<z<−0.5 | 0.5 (0.2, 0.9) | 0.5 (0.2, 1.0) | 0.5 (0.3, 1.1) | 0.5 (0.3, 1.1) | 0.5 (0.2, 1.0) | 0.5 (0.2, 1.0) |
z>−0.5 vs −1<z≤−0.5 | 1.5 (1.0, 2.3) | 1.4 (0.9, 2.1) | 1.2 (0.8, 1.9) | 1.2 (0.8, 1.9) | 1.2 (0.7, 1.8) | 1.3 (0.8, 2.0) |
sHA | p=0.0755 | p=0.0503 | p=0.0507 | p=0.0623 | p=0.0893 | |
z≤−0.5 vs −0.5<z≤1 | 0.7 (0.5, 1.1) | 0.7 (0.5, 1.1) | 0.7 (0.5, 1.1) | 0.7 (0.5, 1.1) | 0.8 (0.5, 1.1) | |
z>1 vs −0.5<z≤1 | 1.4 (0.8, 2.4) | 1.5 (0.9, 2.5) | 1.5 (0.9, 2.5) | 1.5 (0.9, 2.5) | 1.4 (0.8, 2.4) | |
uCTXI ALPHA | p=0.0853 | p=0.3263 | p=0.2818 | |||
z≤−0.5 vs −0.5<z≤0.5 | 0.8 (0.5, 1.2) | 0.8 (0.5, 1.3) | 0.8 (0.5, 1.2) | |||
z>0.5 vs −0.5<z≤0.5 | 1.4 (0.9, 2.1) | 1.4 (0.8, 2.4) | 1.2 (0.8, 1.9) | |||
uNTXI | p=0.9975 | |||||
z≤−0.5 vs −0.5<z≤1 | 1.0 (0.6, 1.7) | |||||
z>1 vs −0.5<z≤1 | 1.0 (0.5, 1.9) | |||||
sNTXI | p=0.2091 | p=0.0414 | ||||
z>1 vs z≤1 | 1.4 (0.8, 2.4) | 1.6 (1.0, 2.6) |
ORs and p values for ORs are unadjusted for covariates: AUC *covariate models adjusted for all covariates (age, sex, body mass index, race, baseline joint space width, Kellgren-Lawrence grade, baseline pain and pain medication use).
AUC, area under the curve; TIC, time-integrated-concentration.